Brainstem lesions in neurofibromatosis type 1
- PMID: 17986937
- DOI: 10.1227/01.NEU.0000298904.63635.2D
Brainstem lesions in neurofibromatosis type 1
Abstract
Objective: The presence of multiple, nonenhancing areas of hyperintensity without mass effect are well recognized on magnetic resonance imaging scans in children with neurofibromatosis type 1 (NF1). Focal regions of brainstem enlargement with or without contrast enhancement are considerably less frequent; the neuroimaging characteristics and natural history of these lesions in patients with NF1 are poorly understood. The objective of this study was to define the clinical and radiographic course of brainstem lesions in children with NF1.
Methods: We retrospectively reviewed the neuroimaging studies of all patients with NF1 between 2000 and 2006 to determine the prevalence of brainstem lesions. Clinical features, previous treatments, and neuroimaging studies of the brainstem lesions were evaluated.
Results: A total of 125 patients underwent neuroimaging studies; of these, 23 patients (18.4%) showed evidence of brainstem mass lesions and had follow-up magnetic resonance imaging scans available for review. Eight patients in this cohort received additional treatment with surgery, radiation, or chemotherapy. Of these, two patients underwent surgery for lesions distant from the brainstem, and six patients underwent treatment that included the brainstem and were thought to potentially affect the natural history or progression of the brainstem abnormality. With a median follow-up period of 67 months for untreated patients (17 out of 23) and 102 months for patients who received therapy (six out of 23), only one previously untreated patient experienced radiographic and clinical progression. All patients but one remain alive.
Conclusion: We conclude that brainstem lesions in NF1 are prevalent and behave in a biologically indolent nature; most do not require therapeutic intervention.
Similar articles
-
A multi-institutional study of brainstem gliomas in children with neurofibromatosis type 1.Neurology. 2017 Apr 18;88(16):1584-1589. doi: 10.1212/WNL.0000000000003881. Epub 2017 Mar 22. Neurology. 2017. PMID: 28330960 Free PMC article.
-
The management of brainstem gliomas in patients with neurofibromatosis 1.Neurology. 1996 Jun;46(6):1652-60. doi: 10.1212/wnl.46.6.1652. Neurology. 1996. PMID: 8649565 Review.
-
Brainstem tumors in patients with neurofibromatosis type 1: a distinct clinical entity.Neurology. 1995 Oct;45(10):1897-902. doi: 10.1212/wnl.45.10.1897. Neurology. 1995. PMID: 7477989
-
Neurofibromatosis type 1 and the pediatric neurosurgeon: a 20-year institutional review.Pediatr Neurosurg. 2002 Sep;37(3):122-36. doi: 10.1159/000064398. Pediatr Neurosurg. 2002. PMID: 12187057
-
[Neurofibromatosis in children. Our experience].Rev Neurol. 2003 Nov 1-15;37(9):820-5. Rev Neurol. 2003. PMID: 14606048 Review. Spanish.
Cited by
-
Four-year follow-up study in a NF1 boy with a focal pontine hamartoma.Ital J Pediatr. 2013 Feb 11;39:10. doi: 10.1186/1824-7288-39-10. Ital J Pediatr. 2013. PMID: 23399325 Free PMC article.
-
CNS Tumors in Neurofibromatosis.J Clin Oncol. 2017 Jul 20;35(21):2378-2385. doi: 10.1200/JCO.2016.71.7199. Epub 2017 Jun 22. J Clin Oncol. 2017. PMID: 28640700 Free PMC article. Review.
-
A multi-institutional study of brainstem gliomas in children with neurofibromatosis type 1.Neurology. 2017 Apr 18;88(16):1584-1589. doi: 10.1212/WNL.0000000000003881. Epub 2017 Mar 22. Neurology. 2017. PMID: 28330960 Free PMC article.
-
Adult brainstem gliomas.Oncologist. 2012;17(3):388-97. doi: 10.1634/theoncologist.2011-0335. Epub 2012 Mar 1. Oncologist. 2012. PMID: 22382458 Free PMC article. Review.
-
Neurofibromatosis type 1 and associated malignancies.Curr Neurol Neurosci Rep. 2009 May;9(3):247-53. doi: 10.1007/s11910-009-0036-3. Curr Neurol Neurosci Rep. 2009. PMID: 19348714 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous